Epigallocatechin gallate sensitizes CAL-27 human oral squamous cell carcinoma cells to the anti-metastatic effects of gefitinib (Iressa) via synergistic suppression of epidermal growth factor receptor and matrix metalloprotei

Epigallocatechin gallate sensitizes CAL-27 human oral squamous cell carcinoma cells to the anti-metastatic effects of gefitinib (Iressa) via synergistic suppression of epidermal growth factor receptor and matrix metalloprotei

Item
http://www.wikidata.org/entity/Q39290727
A multi-targeted approach to suppress tumor-promoting inflammationPotential Compounds for Oral Cancer Treatment: Resveratrol, Nimbolide, Lovastatin, Bortezomib, Vorinostat, Berberine, Pterostilbene, Deguelin, Andrographolide, and ColchicineNicotine may promote tongue squamous cell carcinoma progression by activating the Wnt/β-catenin and Wnt/PCP signaling pathways.Enhancement of gefitinib-induced growth inhibition by Marsdenia tenacissima extract in non-small cell lung cancer cells expressing wild or mutant EGFR.A RXR ligand 6-OH-11-O-hydroxyphenanthrene with antitumour properties enhances (-)-epigallocatechin-3-gallate activity in three human breast carcinoma cell lines.Epigallocatechin-3-gallate enhances the therapeutic effects of leptomycin B on human lung cancer a549 cells.Chemoprevention in gastrointestinal physiology and disease. Targeting the progression of cancer with natural products: a focus on gastrointestinal cancer.Broad targeting of resistance to apoptosis in cancer.Protection of dietary polyphenols against oral cancer.Epigallocatechin-3-gallate, a prototypic chemopreventative agent for protection against cisplatin-based ototoxicity.Role of JNK signaling in oral cancer: A mini review.Beyond the BRAFV600E hotspot: biology and clinical implications of rare BRAF gene mutations in melanoma patients.Association of cancer metabolism-related proteins with oral carcinogenesis - indications for chemoprevention and metabolic sensitizing of oral squamous cell carcinoma?Interleukin-6 role in head and neck squamous cell carcinoma progression.Epigallocatechin-3-gallate affects the proliferation, apoptosis, migration and invasion of tongue squamous cell carcinoma through the hippo-TAZ signaling pathway
P2860

Epigallocatechin gallate sensitizes CAL-27 human oral squamous cell carcinoma cells to the anti-metastatic effects of gefitinib (Iressa) via synergistic suppression of epidermal growth factor receptor and matrix metalloprotei

Item
http://www.wikidata.org/entity/Q39290727
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Epigallocatechin gallate sensi ...... eptor and matrix metalloprotei
@en
Epigallocatechin gallate sensi ...... etastatic effects of gefitinib
@nl
type
label
Epigallocatechin gallate sensi ...... eptor and matrix metalloprotei
@en
Epigallocatechin gallate sensi ...... etastatic effects of gefitinib
@nl
prefLabel
Epigallocatechin gallate sensi ...... eptor and matrix metalloprotei
@en
Epigallocatechin gallate sensi ...... etastatic effects of gefitinib
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Epigallocatechin gallate sensi ...... eptor and matrix metalloprotei
@en
P2093
P304
P31
P356
P433
P478
P50
P577
P5875
P698